Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TAM Receptor Inhibition–Implications for Cancer and the Immune System
Pia Aehnlich, Richard Powell, Marlies J. W. Peeters, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1195-1195
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Macrophages in immunoregulation and therapeutics
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 766
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Dongrui Wang, Xianlin Wu, Yingli Sun
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 290
Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Yanhui Zheng, Yaobao Han, Qiao Sun, et al.
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 118
Leveraging NKG2D Ligands in Immuno-Oncology
Mercedes B. Fuertes, Carolina I. Domaica, Norberto W. Zwirner
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 94
Role of chemokines in the crosstalk between tumor and tumor-associated macrophages
Rui Qin, Weihong Ren, Guoqi Ya, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 5, pp. 1359-1373
Open Access | Times Cited: 67
Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition
Agnete S.T. Engelsen, Maria L. Lotsberg, Raefa Abou Khouzam, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects
Solange Peters, Luis Paz‐Ares, Roy S. Herbst, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004863-e004863
Open Access | Times Cited: 43
Perfluoroalkyl Substances (PFAS) Affect Inflammation in Lung Cells and Tissues
Julie A. Dragon, Michael Hoaglund, Appala Raju Badireddy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8539-8539
Open Access | Times Cited: 32
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
Todd M. Bauer, Byoung Chul Cho, Rebecca S. Heist, et al.
Investigational New Drugs (2022) Vol. 40, Iss. 5, pp. 990-1000
Open Access | Times Cited: 31
Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody–drug Conjugate Targeting AXL-expressing Cancers
Francesca Zammarchi, Karin Havenith, Simon Chivers, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 4, pp. 582-593
Open Access | Times Cited: 30
Engineered drug delivery nanosystems for tumor microenvironment normalization therapy
Beining Yang, Fanze Meng, Jihao Zhang, et al.
Nano Today (2023) Vol. 49, pp. 101766-101766
Closed Access | Times Cited: 21
The complex roles of efferocytosis in cancer development, metastasis, and treatment
Amir Tajbakhsh, Seyed Mohammad Gheibi Hayat, Ahmad Movahedpour, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111776-111776
Open Access | Times Cited: 39
AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew
Almira Auyez, A. Emre Sayan, Marina Kriajevska, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4864-4864
Open Access | Times Cited: 38
Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases
Zeyu Wu, Xiao Yu, Shuijun Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells
Marco Cippitelli, Helena Stabile, Andrea Kosta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1823-1823
Open Access | Times Cited: 13
Pyrrolo[2,3-d]pyrimidines as potential kinase inhibitors in cancer drug discovery: A critical review
Malyala Sai Madhurya, Vanashree Thakur, Sowmya Dastari, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107867-107867
Closed Access | Times Cited: 5
Navigating TAM receptor dynamics in tumour immunotherapy
Jihao Yang, Guanmin Chen, Rui Wang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: A step toward developing innovative anti-cancer therapeutics
Ghazala Muteeb, Doaa S. R. Khafaga, Manar T El-Morsy, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37217-e37217
Open Access | Times Cited: 3
An insight into the TAM system in Alzheimer’s disease
Shiqi Zhou, Yanyan Li, Zhao Zhang, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109791-109791
Closed Access | Times Cited: 9
Two-Front War on Cancer—Targeting TAM Receptors in Solid Tumour Therapy
Agata Mikołajczyk, Filip Mituła, Delfina Popiel, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2488-2488
Open Access | Times Cited: 10
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas
Laurien L. van de Weijer, Emanuela Ercolano, Ting Zhang, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Role of lymphocytes, macrophages and immune receptors in suppression of tumor immunity
Aayushi Singh, Vandana Anang, Komal Kumari, et al.
Progress in molecular biology and translational science (2022), pp. 269-310
Closed Access | Times Cited: 8
Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies
Ava Safaroghli‐Azar, Fatemeh Emadi, Jimma Likisa Lenjisa, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103525-103525
Closed Access | Times Cited: 4
TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process
Xinyu Shao, Yibin Sun, Kaiqiang Zhong, et al.
Aging (2023)
Open Access | Times Cited: 4
Disulfidptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Cancer
Shanping Shi, Xiaojian Tang, Hua Liu
Reproductive Sciences (2023) Vol. 31, Iss. 3, pp. 811-822
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top